Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioAge Labs, Inc. - Common Stock
(NQ:
BIOA
)
9.220
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
9.220
Bid (Size)
7.710 (100)
Ask (Size)
9.550 (100)
Prev. Close
9.220
Today's Range
9.220 - 9.220
52wk Range
2.880 - 20.37
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
November 07, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
Performance
YTD
+65.8%
+65.8%
1 Month
+24.3%
+24.3%
3 Month
+94.5%
+94.5%
6 Month
+115.9%
+115.9%
1 Year
-46.6%
-46.6%
More News
Read More
BioAge Labs Inc (NASDAQ:BIOA) Reports Q3 2025 Earnings with Significant Revenue Beat
↗
November 06, 2025
Via
Chartmill
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 06, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
↗
November 05, 2025
Via
The Motley Fool
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
↗
October 29, 2025
Via
The Motley Fool
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
↗
October 26, 2025
Via
The Motley Fool
Here are the top movers in Thursday's session.
↗
October 23, 2025
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 23, 2025
Via
Benzinga
Which stocks are moving on Thursday?
↗
October 23, 2025
Via
Chartmill
These stocks are gapping in today's session
↗
October 23, 2025
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
October 23, 2025
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 23, 2025
Via
Benzinga
This Badger Meter Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
↗
October 22, 2025
Via
Benzinga
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
BioAge Labs to Present at Upcoming Investor Conferences
August 20, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
August 15, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M
↗
August 06, 2025
Via
The Motley Fool
Topics
Intellectual Property
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 06, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
June 21, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
June 17, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
June 03, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
May 29, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present at Upcoming Investor Conferences
May 27, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is BioAge Labs, Inc. - Common Stock publicly traded?
Yes, BioAge Labs, Inc. - Common Stock is publicly traded.
What exchange does BioAge Labs, Inc. - Common Stock trade on?
BioAge Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioAge Labs, Inc. - Common Stock?
The ticker symbol for BioAge Labs, Inc. - Common Stock is BIOA on the Nasdaq Stock Market
What is the current price of BioAge Labs, Inc. - Common Stock?
The current price of BioAge Labs, Inc. - Common Stock is 9.220
When was BioAge Labs, Inc. - Common Stock last traded?
The last trade of BioAge Labs, Inc. - Common Stock was at 12/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today